Loading clinical trials...
Loading clinical trials...
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Fixed Single-dose Regimen, Multicenter Study to Assess the Efficacy and Safety of SR141716 in Obese Type 2 Diabetic Patients Inadequately Controlled With Diet and Exercise Alone
Conditions
Interventions
Rimonabant
placebo (for Rimonabant)
+1 more
Locations
1
Japan
Sanofi-Aventis Administrative Office
Tokyo, Japan
Start Date
April 1, 2007
Primary Completion Date
January 1, 2009
Completion Date
January 1, 2009
Last Updated
June 8, 2016
NCT01143454
NCT07472881
NCT07010757
NCT06989203
NCT06223555
NCT07237750
Lead Sponsor
Sanofi
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions